CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to HSCSW

Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10

Phase 2
HeartSciences Inc. (HSCSW)

Phase 2

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Non-Malignant Neoplasm

View Full Landscape
Drug Information

Target Indication

Non-Malignant Neoplasm

Clinical Trial

NCT04083183

Last updated: 8/18/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.